Aigen Investment Management LP Boosts Stock Position in Teleflex Incorporated (NYSE:TFX)

Key Points

• Aigen Investment Management LP increased its stake in Teleflex Incorporated by 198.5% in the first quarter, acquiring an additional 3,080 shares for a total valuation of $640,000.
• Teleflex announced a quarterly dividend of $0.34, with a yield of 1.2%, payable on September 15th to investors of record as of August 15th.
• In its latest earnings report, Teleflex reported $3.73 EPS, surpassing estimates, and experienced a 4.2% year-over-year revenue increase totaling $780.9 million during the quarter.

Aigen Investment Management LP grew its position in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 198.5% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,632 shares of the medical technology company's stock after purchasing an additional 3,080 shares during the quarter. Aigen Investment Management LP's holdings in Teleflex were worth $640,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of TFX. MassMutual Private Wealth & Trust FSB boosted its stake in shares of Teleflex by 103.1% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company's stock worth $27,000 after buying an additional 100 shares during the last quarter. Banque Cantonale Vaudoise bought a new stake in Teleflex during the first quarter worth approximately $27,000. Costello Asset Management INC bought a new stake in shares of Teleflex during the 1st quarter worth approximately $28,000. Whipplewood Advisors LLC raised its holdings in shares of Teleflex by 7,700.0% in the first quarter. Whipplewood Advisors LLC now owns 234 shares of the medical technology company's stock valued at $32,000 after acquiring an additional 231 shares in the last quarter. Finally, Allworth Financial LP lifted its holdings in Teleflex by 504.8% during the first quarter. Allworth Financial LP now owns 254 shares of the medical technology company's stock worth $34,000 after buying an additional 212 shares during the period. 95.62% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the company. Wells Fargo & Company reduced their target price on Teleflex from $137.00 to $131.00 and set an "equal weight" rating for the company in a research note on Friday, August 1st. Truist Financial lowered their price objective on Teleflex from $140.00 to $137.00 and set a "hold" rating on the stock in a report on Monday, May 5th. Royal Bank Of Canada boosted their target price on Teleflex from $130.00 to $135.00 and gave the stock a "sector perform" rating in a report on Friday, August 1st. Mizuho upped their price objective on Teleflex from $130.00 to $135.00 and gave the company a "neutral" rating in a report on Friday, August 1st. Finally, Morgan Stanley cut their target price on Teleflex from $191.00 to $173.00 and set an "overweight" rating on the stock in a research report on Monday, May 5th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating, one has given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $141.57.

Insider Buying and Selling at Teleflex

In other Teleflex news, CEO Liam Kelly bought 1,500 shares of the firm's stock in a transaction that occurred on Tuesday, August 5th. The stock was bought at an average price of $115.07 per share, for a total transaction of $172,605.00. Following the completion of the acquisition, the chief executive officer directly owned 45,267 shares in the company, valued at $5,208,873.69. The trade was a 3.43% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Gretchen R. Haggerty bought 500 shares of the business's stock in a transaction dated Wednesday, August 6th. The stock was bought at an average cost of $114.75 per share, for a total transaction of $57,375.00. Following the completion of the purchase, the director owned 6,305 shares of the company's stock, valued at approximately $723,498.75. The trade was a 8.61% increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders purchased 5,500 shares of company stock worth $633,590. 1.40% of the stock is currently owned by insiders.

Teleflex Price Performance

Shares of NYSE:TFX traded down $0.29 during midday trading on Friday, reaching $120.87. 154,154 shares of the company's stock were exchanged, compared to its average volume of 796,285. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.44 and a current ratio of 2.41. The firm has a market capitalization of $5.34 billion, a PE ratio of 28.44, a price-to-earnings-growth ratio of 1.71 and a beta of 1.08. Teleflex Incorporated has a 12 month low of $108.90 and a 12 month high of $249.90. The company's 50 day simple moving average is $117.97 and its two-hundred day simple moving average is $133.22.

Teleflex (NYSE:TFX - Get Free Report) last issued its earnings results on Thursday, July 31st. The medical technology company reported $3.73 earnings per share for the quarter, topping analysts' consensus estimates of $3.36 by $0.37. The business had revenue of $780.90 million for the quarter, compared to the consensus estimate of $771.53 million. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. The firm's revenue for the quarter was up 4.2% on a year-over-year basis. During the same period in the previous year, the company earned $3.42 earnings per share. Equities research analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 15th. Shareholders of record on Friday, August 15th will be paid a dividend of $0.34 per share. The ex-dividend date is Friday, August 15th. This represents a $1.36 annualized dividend and a yield of 1.1%. Teleflex's dividend payout ratio (DPR) is 32.00%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.